Clinical trial
Effect of V0251 in Acute Vertigo
NCT01583738 is registered in ClinicalTrials.gov with Pierre Fabre Medicament as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of V0251 in Acute Vertigo
- Lead sponsor
- Pierre Fabre Medicament
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2012
- Completion date
- April 30, 2013
- Enrollment
- 132 (actual)
- Sites
- 40
Conditions
As the registry lists them; a condition with its own page is linked.
acute vertigo